Join the Way That Suits You Best! Attend In-Person in Jeddah, Saudi Arabia, or Virtually from Anywhere in the World!

Speaker Details

  • Home
  • Dr. Tahiri Yasmin
team member image

Dr. Tahiri Yasmin

University Hospital Ibn Rochd of Casablanca

Dr TAHIRI Yasmin born in 1994, a third-year gastroenterology resident at the University Hospital of Casablanca in Morocco, driven by a strong passion for this specialty. Through my training, I have developed a deep interest in advancing knowledge within the field, particularly through scientific research. I am committed to contributing to the medical community by combining evidence-based practice with innovative research to improve patient outcomes in gastroenterology.

Morocco
Abstracts
2024
Platelet-Lymphocyte Ratio: A Useful Biomarker for Predicting Endoscopic Activity in Crohn's Disease

Introduction: The platelet-to-lymphocyte ratio (PLR) is gaining attention as a biomarker for various diseases, including Crohn's disease (CD). Assessing CD activity usually involves invasive ileocolonoscopy, which limits its practicality. This study aims to evaluate the correlation between PLR and endoscopic activity in CD patients.
Methods: This retrospective descriptive and analytical study was conducted between January 2019 and April 2023 at a University Hospital, including 116 CD patients. Patients were categorized based on their simplified endoscopic score for Crohn's disease (SES-CD): inactive/mild activity (SES-CD ≤ 6) and moderate/severe activity (SES-CD > 6). Data were analyzed using SPSS v26, and Pearson's coefficient was used to assess the correlation between PLR and disease activity (p < 0.05).
Results: The study found that patients with moderate/severe flare-ups (SES-CD > 6) had significantly higher PLR (336.7 vs. 205.4; p = 0.005). A positive correlation between PLR and endoscopic activity was observed (r = 0.271, p = 0.005), with an area under the ROC curve of 0.646 (p = 0.009).
Conclusion: PLR demonstrates a significant correlation with endoscopic activity in CD and could serve as a cost-effective, non-invasive biomarker for predicting moderate to severe disease activity.

Featured 2025 Speakers

Speakers of The Club

team member image
Prof. Dorota Zarebska-Michaluk
Vice-President - Polish Association for the Study of the Liver
team member image
Adriana Botezatu
Nicolae Testemitanu SUMPh of Republic of Moldova
team member image
Prof. Hwoon-Yong Jung
Asan Medical Center, University of Ulsan College of Medicine
team member image
Omar Khokhar
University of Illinois College of Medicine-Peoria
team member image
Feng Zhang
Department of Surgery, Klinikum rechts der Isar, School of Medicine, Technical University of Munich
team member image
Dr. Geesala Ramasatyaveni
Research Scientist, Stem Cell Biology, Gut Physiology - The University of Texas Medical Branch
team member image
Dr. Manar Fartmissi
Gastroenterology Department, Ibn Rochd University Hospital Center
team member image
Dr. Aren Nersisyan
Gastro Clinic
team member image
Dr. Alia Abdalla Ibrahim
Al Habib Hospital
vector vector vector
WhatsApp Click to Chat